Molecular basis of the inefficacy and possible harmful effects of AIDS vaccine candidates based on HIV-1 envelope glycoprotein gp120

By Veljkovic V.   Johnson E.   Metlas R.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 473-474

Elsevier

Access to resources Recommend Favorite

Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons

By Vinner L.   Nielsen H.V.   Bryder K.   Corbet S.   Claus Nielsen   Fomsgaard A.  

Vaccine, Vol. 17, Iss. 17, 1999-04 ,pp. : 2166-2175

Elsevier

Access to resources Recommend Favorite

A molecular and serologic study of the envelope gene of the British isolate: HIV-1 GB8

By Vella C.   Smith M.H.   Farrar G.H.   Jones D.H.   Daniels R.S.  

Vaccine, Vol. 13, Iss. 8, 1995-06 ,pp. : 735-741

Elsevier

Access to resources Recommend Favorite

Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials

By Gilbert P.B.   Chiu Y.-L.   Allen M.   Lawrence D.N.   Chapdu C.   Israel H.   Holman D.   Keefer M.C.   Wolff M.   Frey S.E.   NIAID HIV Vaccine Trials Network  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2933-2947

Elsevier

Access to resources Recommend Favorite

Development of peptide vaccines inducing production of neutralizing antibodies against HIV-1 viruses in HLA-DQ6 mice

By Takahashi A.   Ogasawara K.   Matsuki N.   Fujinaga K.   Nakaya T.   Ikuta K.   Auwanit W.   Honda M.   Fukui Y.   Sasazuki T.   Iwabuchi K.   Onoe K.  

Vaccine, Vol. 16, Iss. 16, 1998-10 ,pp. : 1537-1543

Elsevier

Access to resources Recommend Favorite